Technical Analysis for NVCN - Neovasc Inc.

Grade Last Price % Change Price Change
grade D 2.89 -7.67% -0.24
NVCN closed down 7.67 percent on Wednesday, November 13, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical NVCN trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -7.67%
Stochastic Reached Oversold Weakness -7.67%
Below Lower BB Weakness -7.67%

Older signals for NVCN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; and Tiara technology in development for the transcatheter treatment of mitral valve disease. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products, including transcatheter heart valves. In addition, the company provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, it offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Medicine Medical Specialties Medical Devices Circulatory System Interventional Cardiology Cardiac Surgery Cardiovascular Products Cardiovascular Edwards Lifesciences Heart Valve Valvular Heart Disease
Is NVCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.23
52 Week Low 0.372
Average Volume 62,044
200-Day Moving Average 1.9252
50-Day Moving Average 3.6305
20-Day Moving Average 3.6453
10-Day Moving Average 3.5295
Average True Range 0.2506
ADX 29.79
+DI 12.6614
-DI 27.2701
Chandelier Exit (Long, 3 ATRs ) 3.3182
Chandelier Exit (Short, 3 ATRs ) 3.6418
Upper Bollinger Band 4.2016
Lower Bollinger Band 3.089
Percent B (%b) -0.18
BandWidth 30.521493
MACD Line -0.1025
MACD Signal Line 0.0014
MACD Histogram -0.1039
Fundamentals Value
Market Cap 228.05 Million
Num Shares 78.9 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -41.29
Price-to-Sales 13.79
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.34
Resistance 3 (R3) 3.39 3.29 3.27
Resistance 2 (R2) 3.29 3.18 3.27 3.24
Resistance 1 (R1) 3.09 3.10 3.04 3.04 3.21
Pivot Point 2.99 2.99 2.97 2.97 2.99
Support 1 (S1) 2.79 2.88 2.74 2.74 2.57
Support 2 (S2) 2.69 2.80 2.67 2.54
Support 3 (S3) 2.49 2.69 2.52
Support 4 (S4) 2.44